Cargando…
367. Influence of Body Weight and Outcomes in Candidemia
BACKGROUND: Obese patients may have altered pharmacokinetic parameters when compared with normal weight patients due to their body habitus and altered drug clearance. Case reports suggest higher echinocandin dosing may be needed to reach adequate serum concentrations in obese patients. The purpose o...
Autores principales: | Musgrove, Mary, Kenney, Rachel M, Davis, Susan, Vazquez, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255340/ http://dx.doi.org/10.1093/ofid/ofy210.378 |
Ejemplares similares
-
Communicating Microbiology Results. It’s Not Just What You Say, But How You Say It
por: Musgrove, Mary, et al.
Publicado: (2017) -
Validation of an Empiric Candidemia Treatment Algorithm
por: Stack, Conor M, et al.
Publicado: (2017) -
MED8/367: Developing an Internet-based Informatics Diploma
por: Parry, DT, et al.
Publicado: (1999) -
637. Outcomes by Body Mass Index (BMI) in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Caspofungin
por: Vazquez, Jose A, et al.
Publicado: (2020) -
1692. Epidemiology, Clinical Characteristics, and Outcomes of Candidemia in a Tertiary Hospital in the Dominican Republic
por: Rojas Fermin, Rita, et al.
Publicado: (2019)